S100A9 and hypertriglyceridemia: By affecting different immune niches in the liver and SkM, S100A9 rescues hypertriglyceridemia and hyperketonemia and stimulates SkM glucose uptake via Toll-like-receptor 4 (TLR4)-dependent mechanism.